Cascade-activatable NO release based on GSH-detonated “nanobomb” for multi-pathways cancer therapy
Yi Feng(Army Medical University), Yiyao Liu(University of Electronic Science and Technology of China), Hong Yang(University of Electronic Science and Technology of China), Ningxi Li(University of Electronic Science and Technology of China), Fengming You(Chengdu University of Traditional Chinese Medicine), Xiaodan Wei(Sanofi (United States)), Hanxi Zhang(Nanjing Drum Tower Hospital), Yu Chen(Shanghai University), Tingting Li(University of Electronic Science and Technology of China), Shun Li, Geng Yang(Power Systems Engineering Research Center), Xiaoxue Xie(China Pharmaceutical University), Chunhui Wu(University of Electronic Science and Technology of China), Mengyue Li(University of Electronic Science and Technology of China), Xiang Qin(University of Electronic Science and Technology of China)
Cited by 48
Related Papers
Reactive Oxygen Species (ROS)-Based Nanomedicine
|Chemical Reviews|2019|2.4k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Hollow/Rattle-Type Mesoporous Nanostructures by a Structural Difference-Based Selective Etching Strategy
|ACS Nano|2009|649
Core/Shell Structured Hollow Mesoporous Nanocapsules: A Potential Platform for Simultaneous Cell Imaging and Anticancer Drug Delivery
|ACS Nano|2010|625
Nanocatalytic Medicine
|Advanced Materials|2019|605